Both in Biotechnology
Biogen vs Bio-Techne
Over the past year BIIB returned +67.5% and TECH returned +18.6%; their daily moves had a correlation of 0.11.
BIIB +67.5% TECH +18.6%Growth of $1, one year, split-adjusted
| Metric | BIIB | TECH |
|---|---|---|
| Price | $253.62 | $72.66 |
| Market cap | $37.49B | $11.41B |
| Today | +1.59% | −0.07% |
| 1 month | +13.8% | +0.4% |
| 6 months | +35.6% | +32.1% |
| Year to date | +44.1% | +23.6% |
| 1 year | +71.5% | +17.2% |
| Revenue growth (YoY) | +10.6% | +1.3% |
| Gross margin | 73.3% | 65.8% |
| Net margin | −0.7% | 17.0% |
| P/E (TTM) | 107.9× | 62.7× |
| Price / sales | 3.6× | 9.4× |
| Net cash | -$6.39B | $64.7M |
| Dividend yield | — | 0.44% |
| Volatility (60d) | 27.9% | 2.5% |
| Short % of float | 3.7% | 4.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).